Skip to main content
Premium Trial:

Request an Annual Quote

Asuragen Licenses BRAF V600E Mutation for Cancer Testing

Premium

Asuragen said this week that it has taken a non-exclusive license to the BRAF V600E mutation from Johns Hopkins University for use in its CLIA laboratory for clinical research and patient testing for a range of cancers.

The presence of the V600E mutation in the BRAF oncogene has been shown to impact prognosis and the prediction of therapeutic response in colorectal cancer and also predicts a poorer prognosis in thyroid cancer, Asuragen said.

The company has integrated the BRAF mutation into its Luminex-based Signature KRAS Mutations assay for research use, and also plans to offer BRAF mutation testing in its services laboratory for clinical trials and companion diagnostics studies.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.